2019 ACR/ARP Annual Meeting

November 8-13, 2019 in Atlanta, GA

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Abstract Number: 199

Obesity and Incident Opioid Use in Rheumatoid Arthritis
Abstract Number: 470

Obesity Is a Robust Predictor of Persistent High Fatigue at 1 Year in Women and Men with Early Rheumatoid Arthritis
Abstract Number: 612

Objective Ankylosing Spondylitis Physical Performance Index (ASPI) Is Highly Reliable and Feasible in Chilean Patients
Abstract Number: 2153

Ocular Scleral Pathology and Relationship with Autoimmune Diseases: Study of 101 Patients from a Single Universitary Centre
Abstract Number: 870

Off-Label Use of Biotherapies to Treat Relapsing And/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)
Abstract Number: 1689

Off-Label Use of Biotherapies to Treat Relapsing And/or Refractory Polyarteritis Nodosa
Abstract Number: 782

Oligoarticular Juvenile Idiopathic Arthritis Displayed Increased Expression of Co-Inhibitory Receptors Without Signs of T-Cell Exhaustion
Abstract Number: 2495

Oligoarticular Psoriatic Arthritis
Abstract Number: 555

Oncostatin M Receptor (OSMR) Underexpression in Patients with Ankylosing Spondylitis
Abstract Number: 1368

One Size Fits All : Replacing ESR by γGT in DAS28 Calculation Permits a Dual Evaluation of Joint Activity Together with Cardiovascular Risk
Abstract Number: 1100

Opioid Overdose Hospitalizations in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Abstract Number: 2048

Opioid Prescription Use Among Patients with Rheumatic Disease: A Population Based Cohort Study
Abstract Number: 215

Opioid Treatment Pattern in a Community Based Rheumatology Clinic
Abstract Number: 2480

Opioid Use Surrounding Diagnosis of Inflammatory Arthritis
Abstract Number: 2056

Opioids Use Among Medicare Beneficiaries with Knee Osteoarthritis: Prevalence and Correlates of Chronic Use
Abstract Number: 2291

Optimal Hydroxychloroquine Drug Levels in Pregnant Women with Systemic Lupus Erythematosus
Abstract Number: 2801

Optimal Threshold of Walking Speed Predictive of Mortality Risk over 9 Years in Knee Osteoarthritis: Data from Osteoarthritis Initiative
Abstract Number: 2680

Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Real Life Study of 134 Patients
Abstract Number: 1135

Optimizing the Management of Flares in Patients with Rheumatoid Arthritis with the Help of Non-Physician Providers: Results of a Randomized Controlled Trial
Abstract Number: 1001

Oral Collagen Type V Supplementation Inhibits Cartilage Degeneration in Experimental Arthritis
Abstract Number: 1740

Orange Brown Chromonychia in Kawasaki Disease: A Clinical Sign That Merits Greater Attention
Abstract Number: 1609

Organ Damage Free Survival in Southern Chinese Patients with Active Lupus Nephritis
Abstract Number: 1310

Osteoarthritis: What’s in a Name?
Abstract Number: 272

Osteoporosis Management Outcomes in a Southern California County Health System
Abstract Number: 2234

Osteoporosis Screening in a Resident-Driven Clinic of a Large Academic Hospital
Abstract Number: 2235

Osteoporosis Screening in African American Patients of Rheumatoid Arthritis Patients: Are We Doing Enough?
Abstract Number: 1295

Otoferlin Is Increased in Muscle and PBMCs from Untreated Children with Juvenile Dermatomyositis: Possible Association with Decreased Circulating Natural Killer Cells
Abstract Number: 767

Outcome Measures in Large-Vessel Vasculitis: Relationships Between Patient, Physician, Imaging, and Laboratory-Based Domains
Abstract Number: 2122

Outcomes and Risk Factors in Septic Arthritis with Underlying Rheumatic Conditions
Abstract Number: 270

Outcomes of a Fracture Liaison Service at an Academic Health Center
Abstract Number: 2846

Outcomes over the First 5 Years of Follow up in a Very Early Rheumatoid Arthritis (RA) Cohort Recruited over 20 Years: Most of the Improvement Occurred Before the 2011 Implementation of Treat-to-Target (T2T)
Abstract Number: 1138

Outpatient Costs and Evaluation and Management (E&M) Expenditure Trends in Rheumatoid Arthritis (RA) Patients Treated with Biologic Therapies in US Community Practices
Abstract Number: 262

Outpatient Healthcare Utilization Among Incident Cases of Systemic Sclerosis: Results from a Population-based Cohort (1988-2016)
Abstract Number: 1208

Outpatient Readmission in Rheumatology: A Machine Learning Predictive Model of Patient’s Return to the Clinic
Abstract Number: 2137

Overall Survival in Patients with PD-1 Inhibitor-related Inflammatory Arthritis and Metastatic Melanoma
Abstract Number: 1587

Oxidized Human Serum Albumin Is Increased in Systemic Lupus Erythematosus, but Not in Rheumatoid Arthritis
Abstract Number: 234

Oxytocin Attenuates Tactile Allodynia in Experimental Fibromyalgia Rats

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z